CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

Showing 6 of 6 entries

View as:

Phase: N/A Priority: Normal

NCT ID: NCT00100724 Org: User:

Start: 04/30/04 End: 07/31/05 Due: 07/31/06

Phase: N/A Priority: Normal

NCT ID: NCT00002402 Org: User:

Start: - End: - Due: -

Phase: N/A Priority: Normal

NCT ID: NCT00103467 Org: User:

Start: 06/30/03 End: - Due: -

Phase: N/A Priority: Normal

NCT ID: NCT00006327 Org: User:

Start: 03/31/99 End: 08/31/00 Due: 08/31/01

Phase: N/A Priority: Normal

NCT ID: NCT00103584 Org: User:

Start: 10/31/04 End: 07/31/06 Due: 07/31/07

Phase: N/A Priority: Normal

NCT ID: NCT00002441 Org: User:

Start: - End: - Due: -

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Trial of rPA-102 Vaccine in Healthy Adult Volunteers	NCT00100724	VaxGen	user2@example.com	None	2004-04-30	2005-07-31	2006-07-31	-	-	2025-07-14
A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines	NCT00002402	VaxGen	user2@example.com	None	-	-	-	-	-	2025-07-14
Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine	NCT00103467	VaxGen	user2@example.com	None	2003-06-30	-	-	-	-	2025-07-14
Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand	NCT00006327	VaxGen	user2@example.com	None	1999-03-31	2000-08-31	2001-08-31	-	-	2025-07-14
Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers	NCT00103584	VaxGen	user2@example.com	None	2004-10-31	2006-07-31	2007-07-31	-	-	2025-07-14
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection	NCT00002441	VaxGen	user2@example.com	None	-	-	-	-	-	2025-07-14